Arcutis Biotherapeutics Inc (ARQT)
7.595
-0.36
(-4.47%)
USD |
NASDAQ |
May 07, 14:13
Arcutis Biotherapeutics Gross Profit (TTM): 54.62M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 54.62M |
September 30, 2023 | 45.82M |
June 30, 2023 | 9.344M |
March 31, 2023 | 4.93M |
Date | Value |
---|---|
December 31, 2022 | 2.932M |
September 30, 2022 | 0.456M |
June 30, 2022 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
Jun 2022
54.62M
Maximum
Dec 2023
16.87M
Average
4.93M
Median
Mar 2023
Gross Profit (TTM) Benchmarks
AdaptHealth Corp | 479.56M |
Puma Biotechnology Inc | 166.44M |
Adverum Biotechnologies Inc | -- |
Apellis Pharmaceuticals Inc | 338.08M |
Karuna Therapeutics Inc (DELISTED) | -- |